Search Results 1171-1180 of 17036 for hla genotype
Mayo Clinic doctors and researchers are studying lymphoma to look for new ways to improve diagnosis and treatment for this cancer. Cancer research is conducted ...
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
Damage to the small blood vessels in the kidneys can cause clots that clog the organ's filtering system. This can lead to life-threatening kidney failure.
A Study To Evaluate Pevonedistat, Azacitidine (Or Decitabine), And Venetoclax (PAVE) To Treat Acute Myelogenous Leukemia (AML) Patients · Overview · Participation ...
Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from ...
Researchers from head and neck surgery, thoracic surgery, radiation oncology, hematology/oncology, immunology, and molecular medicine work together to identify ...
If an MTD cannot be identified, a recommended phase 2 dose (RP2D) will be determined. In addition, two tumor specific extension cohorts may be conducted to ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. This is a Phase 2 multicenter, open-label, non-randomized study to examine the safety and effectiveness of BPM31510 administered as a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!